Sarcoidosis with recurrent thrombophlebitis and idiopathic steatorrhoea.

Por Smith, B. D.
Publicado em 1966

DESIGN OF EQUILIBRIUM STAGE PROCESSES.

Por SMITH B D.
Publicado em C1963

Significance of circadian variations of uric acid elimination

Por Owen-Smith, B. D.
Publicado em 1983

Undifferentiated F9 embryonal carcinoma cells produce a short-chain collagen molecule.

Por Smith, B D, Baldwin, C T
Publicado em 1988

Methylation of the alpha 2(I) collagen gene in chemically transformed rat liver epithelial cells.

Por Smith, B D, Marsilio, E
Publicado em 1988

Factors Influencing the Discomfort of Intraoral Needle Penetration

Por Meechan, J. G., Howlett, P. C., Smith, B. D.
Publicado em 2005

RFX family proteins differentially interact with HDACs to repress collagen alpha 2(I) gene (COL1A2) expression

Por Xu, Y., Sengupta, P.K., Seto, E., Smith, B.D.
Publicado em 2006

Successful Integration of Hepatitis C Virus Point-of-Care Tests into the Denver Metro Health Clinic

Por Jewett, A., Al-Tayyib, A. A., Ginnett, L., Smith, B. D.
Publicado em 2013

DNA methylation inhibits transcription of procollagen alpha 2(I) promoters.

Por Guenette, D K, Ritzenthaler, J D, Foley, J, Jackson, J D, Smith, B D
Publicado em 1992

Transforming-growth-factor-beta activation elements in the distal promoter regions of the rat alpha 1 type I collagen gene.

Por Ritzenthaler, J D, Goldstein, R H, Fine, A, Lichtler, A, Rowe, D W, Smith, B D
Publicado em 1991

Key Residues Controlling Binding of Diverse Ligands to Human Cytochrome P450 2A Enzymes

Por DeVore, N. M., Smith, B. D., Wang, J. L., Lushington, G. H., Scott, E. E.
Publicado em 2009

Field-based performance of three pre-market rapid hepatitis C virus antibody assays in STAHR (Study to Assess Hepatitis C Risk) among young adults who inject drugs in San Diego, CA...

Por Jewett, A., Smith, B.D., Garfein, R.S., Cuevas-Mota, J., Teshale, E.H., Weinbaum, C.M.
Publicado no J Clin Virol (2012)

Proceedings: Trial of azathioprine, cyclophosphamide, and gold in rheumatoid arthritis.

Por Woodland, J, Mason, R M, Harris, J, Dixon, A S, Currey, H L, Brownjohn, A M, Davies, J, Owen-Smith, B D
Publicado em 1974

MLN4924 induces Noxa upregulation in acute myelogenous leukemia and synergizes with Bcl-2 inhibitors

Por Knorr, K L B, Schneider, P A, Meng, X W, Dai, H, Smith, B D, Hess, A D, Karp, J E, Kaufmann, S H
Publicado no Cell Death Differ (2015)

Serine Protease Inhibitor-6 Differentially Affects the Survival of Effector and Memory Alloreactive CD8-T Cells

Por Azzi, J., Ohori, S., Ting, C., Uehara, M., Abdoli, R., Smith, B. D., Safa, K., Solhjou, Z., Lukyanchykov, P., Patel, J., McGrath, M., Abdi, R.
Publicado no Am J Transplant (2015)

Clinical, pharmacokinetic and pharmacodynamic data for the MEK1/2 inhibitor pimasertib in patients with advanced hematologic malignancies

Por Ravandi, F, Pigneux, A, DeAngelo, D J, Raffoux, E, Delaunay, J, Thomas, X, Kadia, T, Kantarjian, H, Scheuenpflug, J, Zhao, C, Guo, W, Smith, B D
Publicado no Blood Cancer J (2015)

Induction of high-titer IgG antibodies against multiple leukemia-associated antigens in CML patients with clinical responses to K562/GVAX immunotherapy

Por Qin, L, Smith, B D, Tsai, H-L, Yaghi, N K, Neela, P H, Moake, M, Fu, J, Kasamon, YL, Prince, G T, Goswami, M, Rosner, G L, Levitsky, H I, Hourigan, C S
Publicado em 2013

Expression of putative targets of immunotherapy in acute myeloid leukemia and healthy tissues

Por Goswami, M, Hensel, N, Smith, B D, Prince, G T, Qin, L, Levitsky, H I, Strickland, S A, Jagasia, M, Savani, B N, Fraser, J W, Sadrzadeh, H, Rajkhowa, T, Ito, S, Jain, N A, Battiwalla, M, Fathi, A T, Levis, M J, Barrett, A J, Hourigan, C S
Publicado em 2014